BerandaRGEDF • OTCMKTS
add
Gedeon Richter Ord Shs
Tutup sebelumnya
$27,17
Rentang tahun
$24,01 - $29,58
Rasio P/E
-
Hasil dividen
-
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(HUF) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 216,73 M | 14,95% |
Biaya operasional | 94,69 M | 10,59% |
Laba bersih | 37,06 M | -32,07% |
Margin laba bersih | 17,10 | -40,89% |
Penghasilan per saham | — | — |
EBITDA | 76,39 M | 23,89% |
Tarif pajak efektif | 19,13% | — |
Neraca
Total aset
Total liabilitas
(HUF) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 74,99 M | -29,24% |
Total aset | 1,49 T | 9,53% |
Total liabilitas | 258,83 M | -1,37% |
Total ekuitas | 1,23 T | — |
Saham yang beredar | 182,62 jt | — |
Harga terhadap nilai buku | 0,00 | — |
Tingkat pengembalian aset | 10,29% | — |
Tingkat pengembalian modal | 11,59% | — |
Arus Kas
Perubahan kas bersih
(HUF) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | 37,06 M | -32,07% |
Kas dari operasi | 67,55 M | 56,30% |
Kas dari investasi | -13,69 M | 54,12% |
Kas dari pembiayaan | -36,70 M | -409,23% |
Perubahan kas bersih | 17,12 M | -34,71% |
Arus kas bebas | 13,19 M | 1.594,12% |
Tentang
Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest. It is the largest pharmaceutical company in Central and Eastern Europe, with an expanding direct presence in Western Europe, China, Northern America and Latin America. Richter has the largest R&D unit in Central and Eastern Europe and operations in over 100 countries.
Gedeon Richter Plc. has a primary listing on the Budapest Stock Exchange and is a constituent of the BUX Index. It had a market capitalisation of approximately $6.6 billion as of 2018, the third largest of companies with a primary listing on the Budapest Stock Exchange. It has secondary listings on the Luxembourg Stock Exchange.
Richter sells products for the central nervous system, women's health and cardiovascular therapeutic areas among others. The company is also active in biosimilar product development. The company was established in Budapest by Gedeon Richter, a pharmacist, in 1901. Wikipedia
CEO
Didirikan
1901
Situs
Karyawan
11.603